Prelude Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,382
| Closed | -$22.5K | – | 1262 |
|
|
2025
Q1 | $22.5K | Buy |
+34,382
| New | +$22.5K | ﹤0.01% | 1038 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1778 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1651 |
|
|
2020
Q1 | – | Sell |
-276
| Closed | -$2K | – | 1484 |
|
|
2019
Q4 | $2K | Sell |
276
-48
| -15% | -$348 | ﹤0.01% | 1342 |
|
|
2019
Q3 | $3K | Sell |
324
-39
| -11% | -$361 | ﹤0.01% | 1100 |
|
|
2019
Q2 | $4K | Sell |
363
-425
| -54% | -$4.68K | ﹤0.01% | 1144 |
|
|
2019
Q1 | $8K | Buy |
+788
| New | +$8K | ﹤0.01% | 1159 |
|
|
2018
Q4 | – | Sell |
-42,759
| Closed | -$725K | – | 1707 |
|
|
2018
Q3 | $725K | Hold |
42,759
| – | – | 0.04% | 278 |
|
|
2018
Q2 | $607K | Buy |
42,759
+42,541
| +19,514% | +$604K | 0.04% | 363 |
|
|
2018
Q1 | $4K | Sell |
218
-370
| -63% | -$6.79K | ﹤0.01% | 1271 |
|
|
2017
Q4 | $10K | Sell |
588
-762
| -56% | -$13K | ﹤0.01% | 1068 |
|
|
2017
Q3 | $20K | Sell |
1,350
-813
| -38% | -$12K | ﹤0.01% | 1200 |
|
|
2017
Q2 | $19K | Buy |
+2,163
| New | +$19K | ﹤0.01% | 1160 |
|
|
2015
Q4 | – | Sell |
-3,517
| Closed | -$20K | – | 1576 |
|
|
2015
Q3 | $20K | Sell |
3,517
-983
| -22% | -$5.59K | ﹤0.01% | 1161 |
|
|
2015
Q2 | $50K | Buy |
4,500
+1,700
| +61% | +$18.9K | 0.01% | 1068 |
|
|
2015
Q1 | $44K | Sell |
2,800
-4,400
| -61% | -$69.1K | 0.01% | 1309 |
|
|
2014
Q4 | $110K | Buy |
+7,200
| New | +$110K | 0.02% | 900 |
|
|
2014
Q1 | – | Sell |
-2,700
| Closed | -$38K | – | 1880 |
|
|
2013
Q4 | $38K | Hold |
2,700
| – | – | 0.01% | 1036 |
|
|
2013
Q3 | $28K | Sell |
2,700
-4,076
| -60% | -$42.3K | ﹤0.01% | 1071 |
|
|
2013
Q2 | $53K | Buy |
+6,776
| New | +$53K | 0.01% | 727 |
|